Washington University School of Medicine received a $32 million grant from the National Institute on Aging to expand its longitudinal Alzheimer’s research program through 2031. The work will evaluate real-world treatments and broaden community participation, aiming to strengthen external validity and capture outcomes beyond tightly controlled clinical trial settings.
Get the Daily Brief